BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 34858499)

  • 1. Function of N6-Methyladenosine Modification in Tumors.
    Zhang N; Zuo Y; Peng Y; Zuo L
    J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
    Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R
    Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
    Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA m6A methylation regulators in sepsis.
    Zhu L; Zhang H; Zhang X; Xia L
    Mol Cell Biochem; 2023 Sep; ():. PubMed ID: 37659034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
    Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
    BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine and Neurological Diseases.
    Zhang N; Ding C; Zuo Y; Peng Y; Zuo L
    Mol Neurobiol; 2022 Mar; 59(3):1925-1937. PubMed ID: 35032318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA N
    Melstrom L; Chen J
    Cancer Gene Ther; 2020 Sep; 27(9):625-633. PubMed ID: 31956264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and clinical significance of N6-methyladenosine in digestive system tumours.
    Huang J; Shao Y; Gu W
    Exp Hematol Oncol; 2021 Jul; 10(1):40. PubMed ID: 34246319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and evolution of RNA N6-methyladenosine modification.
    Zhu ZM; Huo FC; Pei DS
    Int J Biol Sci; 2020; 16(11):1929-1940. PubMed ID: 32398960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.